Carboplatin-based primary chemotherapy for infants and young children with CNS tumors

Maryam Fouladi, Sri Gururangan, Albert Moghrabi, Peter Phillips, Lindsey Gronewold, Dana Wallace, Robert A. Sanford, Amar Gajjar, Larry E. Kun, Richard Heideman

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

BACKGROUND: A carboplatin-based chemotherapy regimen was used as primary postoperative therapy in infants with central nervous system (CNS) tumors to limit renal and ototoxicity and to target systemic exposure. METHODS: Fifty-three patients aged <age 3 years with embryonal CNS tumor medulloblastoma (n = 20), ependymoma (EP, n = 21), choroid plexus carcinoma (CPCA, n = 5), and primitive embryonal neoplasms including atypical teratoid rhabdoid tumors (n = 7) were treated with cyclophosphamide, etoposide, and carboplatin. Radiation therapy was used only for residual disease at the end of chemotherapy or disease progression. RESULTS: The response rate after 2 cycles of chemotherapy was 34% (complete response, 13.8%; partial response, 20.7%). Myelosuppression was the dominant toxicity; 2 patients had toxic deaths related to thrombocytopenia with trauma. The 5-year overall survival (OS) was 49% ± 7%, and the progression-free survival (PFS) was 31% ± 7%, with a median follow-up of 11.4 years (range, 5.2-15.0 years). For medulloblastoma, the 5-year PFS was 26% ± 9%; for EP it was 33% ± 10%; for CPCA it was 80% ± 18%; and for primitive neuroectodermal and atypical teratoid rhabdoid tumors it was 0%. Localized EP patients with gross total resection who did not undergo radiotherapy had a 5-year PFS of 57% ± 17% and OS of 71% ± 16%. Two patients developed late second malignancies; 1 was associated with germline p53 mutation. CONCLUSIONS: The results confirm that carboplatin has similar activity to cisplatin in otherwise similar regimens. Five-year survival data are comparable to those reported in other recent studies, including high-dose chemotherapy studies. Of note is the marked activity in CPCA and gross totally resected EP.

Original languageEnglish (US)
Pages (from-to)3243-3253
Number of pages11
JournalCancer
Volume115
Issue number14
DOIs
StatePublished - Aug 18 2009

Fingerprint

Central Nervous System Neoplasms
Carboplatin
Disease-Free Survival
Drug Therapy
Medulloblastoma
Survival
Radiotherapy
Ependymoma
Second Primary Neoplasms
Germ-Line Mutation
Germ Cell and Embryonal Neoplasms
Poisons
Etoposide
Thrombocytopenia
Cyclophosphamide
Cisplatin
Disease Progression
Kidney
Wounds and Injuries
N-cyclopropyl adenosine-5'-carboxamide

Keywords

  • Brain tumor
  • Carboplatin
  • Chemotherapy
  • Infants

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Fouladi, M., Gururangan, S., Moghrabi, A., Phillips, P., Gronewold, L., Wallace, D., ... Heideman, R. (2009). Carboplatin-based primary chemotherapy for infants and young children with CNS tumors. Cancer, 115(14), 3243-3253. https://doi.org/10.1002/cncr.24362

Carboplatin-based primary chemotherapy for infants and young children with CNS tumors. / Fouladi, Maryam; Gururangan, Sri; Moghrabi, Albert; Phillips, Peter; Gronewold, Lindsey; Wallace, Dana; Sanford, Robert A.; Gajjar, Amar; Kun, Larry E.; Heideman, Richard.

In: Cancer, Vol. 115, No. 14, 18.08.2009, p. 3243-3253.

Research output: Contribution to journalArticle

Fouladi, M, Gururangan, S, Moghrabi, A, Phillips, P, Gronewold, L, Wallace, D, Sanford, RA, Gajjar, A, Kun, LE & Heideman, R 2009, 'Carboplatin-based primary chemotherapy for infants and young children with CNS tumors', Cancer, vol. 115, no. 14, pp. 3243-3253. https://doi.org/10.1002/cncr.24362
Fouladi M, Gururangan S, Moghrabi A, Phillips P, Gronewold L, Wallace D et al. Carboplatin-based primary chemotherapy for infants and young children with CNS tumors. Cancer. 2009 Aug 18;115(14):3243-3253. https://doi.org/10.1002/cncr.24362
Fouladi, Maryam ; Gururangan, Sri ; Moghrabi, Albert ; Phillips, Peter ; Gronewold, Lindsey ; Wallace, Dana ; Sanford, Robert A. ; Gajjar, Amar ; Kun, Larry E. ; Heideman, Richard. / Carboplatin-based primary chemotherapy for infants and young children with CNS tumors. In: Cancer. 2009 ; Vol. 115, No. 14. pp. 3243-3253.
@article{0b36052b533e40a79616c7c53fde5860,
title = "Carboplatin-based primary chemotherapy for infants and young children with CNS tumors",
abstract = "BACKGROUND: A carboplatin-based chemotherapy regimen was used as primary postoperative therapy in infants with central nervous system (CNS) tumors to limit renal and ototoxicity and to target systemic exposure. METHODS: Fifty-three patients aged",
keywords = "Brain tumor, Carboplatin, Chemotherapy, Infants",
author = "Maryam Fouladi and Sri Gururangan and Albert Moghrabi and Peter Phillips and Lindsey Gronewold and Dana Wallace and Sanford, {Robert A.} and Amar Gajjar and Kun, {Larry E.} and Richard Heideman",
year = "2009",
month = "8",
day = "18",
doi = "10.1002/cncr.24362",
language = "English (US)",
volume = "115",
pages = "3243--3253",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "14",

}

TY - JOUR

T1 - Carboplatin-based primary chemotherapy for infants and young children with CNS tumors

AU - Fouladi, Maryam

AU - Gururangan, Sri

AU - Moghrabi, Albert

AU - Phillips, Peter

AU - Gronewold, Lindsey

AU - Wallace, Dana

AU - Sanford, Robert A.

AU - Gajjar, Amar

AU - Kun, Larry E.

AU - Heideman, Richard

PY - 2009/8/18

Y1 - 2009/8/18

N2 - BACKGROUND: A carboplatin-based chemotherapy regimen was used as primary postoperative therapy in infants with central nervous system (CNS) tumors to limit renal and ototoxicity and to target systemic exposure. METHODS: Fifty-three patients aged

AB - BACKGROUND: A carboplatin-based chemotherapy regimen was used as primary postoperative therapy in infants with central nervous system (CNS) tumors to limit renal and ototoxicity and to target systemic exposure. METHODS: Fifty-three patients aged

KW - Brain tumor

KW - Carboplatin

KW - Chemotherapy

KW - Infants

UR - http://www.scopus.com/inward/record.url?scp=68549122735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68549122735&partnerID=8YFLogxK

U2 - 10.1002/cncr.24362

DO - 10.1002/cncr.24362

M3 - Article

VL - 115

SP - 3243

EP - 3253

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 14

ER -